Axtria has raised $240 million from Indian private equity giant Kedaara Capital, per an announcement.
Structured as a combination of secondary investment and company-sponsored buyback, the funding provides liquidity to Axtria’s current and former employees, as well as its early investors.
The transaction marks one of the largest employee-centric liquidity events in the industry.
“At Axtria, we are building a company that is not only transforming life sciences through data and agentic AI but also one that values its people and their contributions through long-term value creation,” said Jaswinder Chadha, President & CEO at Axtria.
Established in 2010, Axtria provides cloud software and data analytics to life sciences organisations globally, across the commercial and clinical spectrum. It claims to provide support to more than 100 firms across over 75 countries.
“We look forward to supporting Axtria across organic and inorganic growth opportunities and build on their differentiated value proposition,” said Aashwit Mahajan, Director and Co-Lead, Technology & Technology Services, Kedaara Capital.
Kedaara pursues control and minority investment opportunities in India. It currently manages over $5.5 billion through investments in several market-leading businesses across a variety of sectors including consumer, financial services, pharma/healthcare, and technology/business services. Its portfolio companies include Aavas Financiers, ASG Eye Hospital, and AU Small Finance Bank, among others.
In the AI and data analytics space, Kedaara invested $350 million in Impetus Technologies earlier this year. DealStreetAsia